{"entity":{"type":"insider","cik":"0001532232","url":"/insider/0001532232","json_url":"/insider/0001532232.json","name":"Krassan Mitchell","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2014-01-15","last":"2020-02-05","span_basis":"filed_date"},"name_variants":[{"name":"Krassan Mitchell","source":"filing","n_filings":6,"first_seen":"2014-01-15","last_seen":"2020-02-05"}],"transactions":[{"id":2522347,"accession":"0001387131-20-001050","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001387131-20-001050","line_url":"/filing/0001387131-20-001050#line-3","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532232","owner_name":"Krassan Mitchell","owner_display_name":"Krassan Mitchell","owner_url":"/insider/0001532232","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":2.2564,"price_display":"2.26","price_state":"stated","total_value":676920.0,"total_display":"676,920.00","total_whole":"676,920","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-05","scope":"insider"},{"id":8469830,"accession":"0001387131-15-001922","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-15-001922","line_url":"/filing/0001387131-15-001922#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532232","owner_name":"Krassan Mitchell","owner_display_name":"Krassan Mitchell","owner_url":"/insider/0001532232","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":8.18,"price_display":"8.18","price_state":"stated","total_value":245400.0,"total_display":"245,400.00","total_whole":"245,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-10","scope":"insider"},{"id":8850743,"accession":"0001387131-15-001858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-15-001858","line_url":"/filing/0001387131-15-001858#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532232","owner_name":"Krassan Mitchell","owner_display_name":"Krassan Mitchell","owner_url":"/insider/0001532232","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":6.5559,"price_display":"6.56","price_state":"stated","total_value":393354.0,"total_display":"393,354.00","total_whole":"393,354","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-20","filed_date":"2015-05-22","scope":"insider"},{"id":7079128,"accession":"0001387131-14-000811","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-14-000811","line_url":"/filing/0001387131-14-000811#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532232","owner_name":"Krassan Mitchell","owner_display_name":"Krassan Mitchell","owner_url":"/insider/0001532232","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":7.732,"price_display":"7.73","price_state":"stated","total_value":57990.0,"total_display":"57,990.00","total_whole":"57,990","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-10","filed_date":"2014-03-10","scope":"insider"},{"id":6976502,"accession":"0001387131-14-000477","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-14-000477","line_url":"/filing/0001387131-14-000477#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532232","owner_name":"Krassan Mitchell","owner_display_name":"Krassan Mitchell","owner_url":"/insider/0001532232","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":6.3357,"price_display":"6.34","price_state":"stated","total_value":47517.75,"total_display":"47,517.75","total_whole":"47,518","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-12","scope":"insider"},{"id":6269695,"accession":"0001387131-14-000147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-14-000147","line_url":"/filing/0001387131-14-000147#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001532232","owner_name":"Krassan Mitchell","owner_display_name":"Krassan Mitchell","owner_url":"/insider/0001532232","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":5.7262,"price_display":"5.73","price_state":"stated","total_value":42946.5,"total_display":"42,946.50","total_whole":"42,947","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-13","filed_date":"2014-01-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000025743","name":"TherapeuticsMD, Inc.","url":"/issuer/0000025743","role":"Officer (Chief Strategy Officer)","n_filings":6,"first_seen":"2014-01-15","last_seen":"2020-02-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001532232","retrieved_at":"2026-08-25T21:01:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}